WO2005072893A8 - Functionalized colloidal metal compositions and methods - Google Patents
Functionalized colloidal metal compositions and methodsInfo
- Publication number
- WO2005072893A8 WO2005072893A8 PCT/US2005/003454 US2005003454W WO2005072893A8 WO 2005072893 A8 WO2005072893 A8 WO 2005072893A8 US 2005003454 W US2005003454 W US 2005003454W WO 2005072893 A8 WO2005072893 A8 WO 2005072893A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- methods
- colloidal metal
- metal compositions
- functionalized
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006551620A JP4833862B2 (en) | 2004-01-28 | 2005-01-28 | Functionalized colloidal metal compositions and methods |
EP05722715A EP1715971A4 (en) | 2004-01-28 | 2005-01-28 | Functionalized colloidal metal compositions and methods |
CA002554755A CA2554755A1 (en) | 2004-01-28 | 2005-01-28 | Functionalized colloidal metal compositions and methods |
AU2005209318A AU2005209318B2 (en) | 2004-01-28 | 2005-01-28 | Functionalized colloidal metal compositions and methods |
IL177075A IL177075A (en) | 2004-01-28 | 2006-07-25 | Functionalized colloidal metal compositions and methods |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54007504P | 2004-01-28 | 2004-01-28 | |
US60/540,075 | 2004-01-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005072893A1 WO2005072893A1 (en) | 2005-08-11 |
WO2005072893A8 true WO2005072893A8 (en) | 2005-10-06 |
Family
ID=34826180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/003454 WO2005072893A1 (en) | 2004-01-28 | 2005-01-28 | Functionalized colloidal metal compositions and methods |
Country Status (8)
Country | Link |
---|---|
US (1) | US20050175584A1 (en) |
EP (1) | EP1715971A4 (en) |
JP (1) | JP4833862B2 (en) |
CN (1) | CN1960825A (en) |
AU (1) | AU2005209318B2 (en) |
CA (1) | CA2554755A1 (en) |
IL (1) | IL177075A (en) |
WO (1) | WO2005072893A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7229841B2 (en) | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
NZ504291A (en) * | 1997-11-10 | 2002-10-25 | Cytimmune Sciences Inc | Compositions and methods for targeted delivery of factors |
US20100015068A1 (en) * | 2006-07-06 | 2010-01-21 | Massachusetts Institute Of Technology | Methods and Compositions For Altering Biological Surfaces |
US9056129B2 (en) * | 2007-02-09 | 2015-06-16 | Northeastern University | Precision-guided nanoparticle systems for drug delivery |
JP5142251B2 (en) * | 2007-04-20 | 2013-02-13 | 国立大学法人大阪大学 | Composite particles using gold iron oxide particles and MRI contrast agent |
US8877156B2 (en) | 2007-06-26 | 2014-11-04 | New York University | Contrast agents anchored by thiols on nanoparticles |
JP2009057311A (en) * | 2007-08-31 | 2009-03-19 | Nof Corp | Metal salt-reducing agent, method for producing metal fine particles, method for producing metal fine particle-liposome composite, and material for medical care |
KR20100123674A (en) * | 2007-09-21 | 2010-11-24 | 싸이티뮨 사이언스, 인크. | Nanotherapeutic colloidal metal compositions and methods |
US20110014118A1 (en) * | 2007-09-21 | 2011-01-20 | Lawrence Tamarkin | Nanotherapeutic colloidal metal compositions and methods |
EP2205282A2 (en) | 2007-09-24 | 2010-07-14 | Bar-Ilan University | Polymer nanoparticles coated by magnetic metal oxide and uses thereof |
CA2706700A1 (en) | 2007-11-08 | 2009-05-14 | Cytimmune Sciences, Inc. | Compositions and methods for generating antibodies |
JP2011515330A (en) * | 2008-01-30 | 2011-05-19 | ファルマ・マール・ソシエダード・アノニマ | Improved antitumor treatment |
WO2009109649A1 (en) * | 2008-03-07 | 2009-09-11 | Pharma Mar, S.A. | Improved antitumoral treatments |
US20120076848A1 (en) * | 2009-07-22 | 2012-03-29 | Kambiz Thomas Moazed | Method and system for effecting changes in pigmented tissue |
US8784895B2 (en) | 2011-03-15 | 2014-07-22 | Northwestern University | Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same |
US9095625B2 (en) | 2012-08-31 | 2015-08-04 | University Of Massachusetts | Graft-copolymer stabilized metal nanoparticles |
JP2016511747A (en) | 2013-01-04 | 2016-04-21 | マサチューセッツ インスティテュート オブ テクノロジー | Drug delivery to tissues based on nanoparticle surface binding |
GB2510587B (en) * | 2013-02-07 | 2020-05-20 | Orthopaedic Res Uk | Biospecific agents for bone |
KR101681114B1 (en) * | 2015-01-23 | 2016-12-01 | 한국과학기술연구원 | Surface modified nanoparticles, and colorimetric detection sensor for zinc ion using the same |
Family Cites Families (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3145144A (en) * | 1951-08-09 | 1964-08-18 | Takeda Pharmacentical Ind Ltd | Process for manufacturing chromium treated vaccines |
US2768958A (en) * | 1954-04-08 | 1956-10-30 | Goodrich Co B F | Colloidal dispersions of heavy metal compounds |
US2785153A (en) * | 1954-09-13 | 1957-03-12 | Crookes Barnes Lab Inc | Silver protein |
US3149036A (en) * | 1961-10-16 | 1964-09-15 | Merck & Co Inc | Adjuvant vaccine with aluminum monostearate, mannide monooleate, vegetable oil, and an aqueous phase immunolgical agent |
US3269912A (en) * | 1963-04-08 | 1966-08-30 | Boehringer & Soehne Gmbh | Aluminum oxide depot vaccines |
US3399263A (en) * | 1965-04-12 | 1968-08-27 | American Cyanamid Co | Stable adjuvant emulsion compositions comprising the hydrated reaction products of a methallic cation and a fatty acid |
US3651211A (en) * | 1967-10-16 | 1972-03-21 | Lockheed Aircraft Corp | Virus inactivation |
US3819820A (en) * | 1968-07-31 | 1974-06-25 | J Lorina | Irradiated substance and compound and method of preparing the same |
US3577523A (en) * | 1969-03-07 | 1971-05-04 | Miles Lab | Water-insoluble antigenic substances and method of preparing the same and antigenic depot agents incorporating such substances |
US3531565A (en) * | 1969-09-25 | 1970-09-29 | American Cyanamid Co | Stable adjuvant emulsion compositions comprising hydrated salts of a polyvalent metallic cation and a higher fatty acid |
US4339437A (en) * | 1976-12-27 | 1982-07-13 | Research Corporation | Anti-tumor method |
US4177263A (en) * | 1972-02-28 | 1979-12-04 | Research Corporation | Anti-animal tumor method |
US4016252A (en) * | 1972-04-06 | 1977-04-05 | Institut Pasteur | Calcium phosphate gel for adsorbing vaccines |
US4053587A (en) * | 1973-04-13 | 1977-10-11 | Research Corporation | Method of treating viral infections |
US4197237A (en) * | 1973-06-01 | 1980-04-08 | Syva Company | Antibodies to nitrogen derivatives of benzoyl ecgonine antigenic conjugates thereof |
US3983228A (en) * | 1973-08-28 | 1976-09-28 | Merck & Co., Inc. | Water-in-oil adjuvant composition |
US3919413A (en) * | 1973-10-12 | 1975-11-11 | Univ Nebraska | Vaccine for neonatal calf diarrhea |
US4069313A (en) * | 1974-11-19 | 1978-01-17 | Merck & Co., Inc. | Water-in-oil adjuvant composition |
US4218436A (en) * | 1977-09-21 | 1980-08-19 | The Upjohn Company | Compounds and methods |
US4197286A (en) * | 1977-09-27 | 1980-04-08 | Southwest Research Institute | Testosterone derivatives and assay method |
US4329281A (en) * | 1978-06-05 | 1982-05-11 | Hoffmann-La Roche Inc. | Hapten compositions |
US4196185A (en) * | 1978-06-05 | 1980-04-01 | Hoffmann-La Roche Inc. | Immunoassay for phencyclidine |
US4215036A (en) * | 1978-08-15 | 1980-07-29 | Research Corporation | Modified grass pollen antigens |
NZ191327A (en) * | 1978-08-24 | 1981-07-13 | W B Martin | Pasteurellosis vaccine comprising antigenic material derived from the a1 and a2 serotypes of pasteurella haemolytica |
US4213964A (en) * | 1978-12-07 | 1980-07-22 | Miles Laboratories, Inc. | Diphenylhydantoin antibodies |
US4487780A (en) * | 1979-09-18 | 1984-12-11 | Scheinberg Israel H | Method of treatment of rheumatoid arthritis |
US4332787A (en) * | 1980-06-23 | 1982-06-01 | The Massachusetts General Hospital | Assay for beta-adrenergic antagonists and antibody therefor |
US4330530A (en) * | 1980-12-22 | 1982-05-18 | The Procter & Gamble Company | Anti-arthritic compositions and method using gold salts and organophosphonates |
US4594325A (en) * | 1981-03-26 | 1986-06-10 | The Regents Of The University Of Calif. | High fusion frequency fusible lymphoblastoid cell line |
US4451570A (en) * | 1981-03-26 | 1984-05-29 | The Regents Of The University Of California | Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line |
US4608252A (en) * | 1981-04-23 | 1986-08-26 | Syntex (U.S.A.) Inc. | Chloramphenicol derivatives antigens and antibodies |
CA1214123A (en) * | 1983-01-20 | 1986-11-18 | Masashi Matsui | Cell lines for use in the preparation of hybridoma cells |
HU188847B (en) * | 1983-02-22 | 1986-05-28 | Human Oltoanyagtermeloe Es Kutato Intezet,Hu | Process for producing liophylized combined vaccines |
NO162241C (en) * | 1983-06-14 | 1989-11-29 | Roussel Uclaf | NEW RADIOACTIVE ESTRADIA DERIVATIVES LABELED WITH JOD125, THE PROCEDURE OF THEIR PREPARATION AND THEIR USE OF RADIO DIMMUNOLOGICAL RESEARCH AND QUANTITY DETERMINATION OF STEROIDS IN BIOLOGICAL LIQUIDS. |
JPH0720878B2 (en) * | 1983-11-21 | 1995-03-08 | ザ ウエルカム フアウンデ−シヨン リミテツド | Improved conjugates, processes for their production and formulations containing the conjugates |
JPS60193925A (en) * | 1984-03-13 | 1985-10-02 | Chemo Sero Therapeut Res Inst | Lyophilized pharmaceutical preparation vaccine |
CA1224003A (en) * | 1984-04-24 | 1987-07-14 | Robert S. Molday | Colloidal sized metal-polysaccharide particles |
US4624921A (en) * | 1984-04-26 | 1986-11-25 | Cetus Corporation | Human lymphoblastold cell line and hybridomas derived therefrom |
US4624923A (en) * | 1984-06-08 | 1986-11-25 | Yeda Research And Development Company Limited | Metal-coated polyaldehyde microspheres |
US4882423A (en) * | 1984-10-02 | 1989-11-21 | Calpis Food Industry | Substance-conjugated complement component C1q |
US5035995A (en) * | 1984-10-02 | 1991-07-30 | Calpis Food Industry Co., Ltd. | Test method involving substance-conjugated complement component C1q |
US5019497A (en) * | 1984-11-09 | 1991-05-28 | Lennart Olsson | Human squamous lung carcinoma cell specific antigens and antibodies |
US4693975A (en) * | 1984-11-20 | 1987-09-15 | The Wistar Institute | Human hybridroma fusion partner for production of human monoclonal antibodies |
US4720459A (en) * | 1985-02-14 | 1988-01-19 | Medical College Of Wisconsin Research Foundation, Inc. | Myelomas for producing human/human hybridomas |
US4657763A (en) * | 1985-09-03 | 1987-04-14 | Michael Ebert | Combined chrysotherapeutic agents for autoimmune diseases |
JPS62162963A (en) * | 1986-01-10 | 1987-07-18 | Sadao Shiosaka | Specific antibody of low molecular material prepared by using metallic colloid particle as carrier and preparation thereof |
US4753873A (en) * | 1986-02-03 | 1988-06-28 | Cambridge Bioscience Corporation | Peptides for the diagnosis of HTLV-III antibodies, their preparation and use |
US4906564A (en) * | 1987-03-13 | 1990-03-06 | The United States Of America As Represented By The Secretary Of The Army | Antigenic determinants recognized by antibodies obtained using a pathogenic agent or a derivative thereof that presents a restricted set of antigens |
US4812556A (en) * | 1987-05-18 | 1989-03-14 | Virovahl | Synthetic peptide antigen for the detection of HIV-2 infection |
US4880750A (en) * | 1987-07-09 | 1989-11-14 | Miragen, Inc. | Individual-specific antibody identification methods |
US5017687A (en) * | 1988-03-10 | 1991-05-21 | Virovahl, S.A. | Peptides for the detection of HTLV-1 infection |
US5089424A (en) * | 1988-06-14 | 1992-02-18 | Abbott Laboratories | Method and apparatus for heterogeneous chemiluminescence assay |
US5047523A (en) * | 1988-08-02 | 1991-09-10 | Ortho Diagnostic Systems Inc. | Nucleic acid probe for detection of neisseria gonorrhoea |
US4977286A (en) * | 1988-09-09 | 1990-12-11 | Trustees Of The University Of Pennsylvania | Glycolipids |
SE462454B (en) * | 1988-11-10 | 1990-06-25 | Pharmacia Ab | METHOD FOR USE IN BIOSENSORS |
US5376556A (en) * | 1989-10-27 | 1994-12-27 | Abbott Laboratories | Surface-enhanced Raman spectroscopy immunoassay |
DE69125992T2 (en) * | 1990-09-14 | 1997-08-21 | Tosoh Corp | Method and kit for immunoassay |
US5466609A (en) * | 1990-10-31 | 1995-11-14 | Coulter Corporation | Biodegradable gelatin-aminodextran particle coatings of and processes for making same |
US5169754A (en) * | 1990-10-31 | 1992-12-08 | Coulter Corporation | Biodegradable particle coatings having a protein covalently immobilized by means of a crosslinking agent and processes for making same |
US5294369A (en) * | 1990-12-05 | 1994-03-15 | Akzo N.V. | Ligand gold bonding |
JP3220180B2 (en) * | 1991-05-23 | 2001-10-22 | 三菱化学株式会社 | Drug-containing protein-bound liposomes |
US5248772A (en) * | 1992-01-29 | 1993-09-28 | Coulter Corporation | Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
US5736410A (en) * | 1992-09-14 | 1998-04-07 | Sri International | Up-converting reporters for biological and other assays using laser excitation techniques |
JP3746293B2 (en) * | 1993-02-22 | 2006-02-15 | アメリカン バイオサイエンス、インコーポレイテッド | Methods for in vivo delivery of biologics and compositions therefor |
US6274552B1 (en) * | 1993-03-18 | 2001-08-14 | Cytimmune Sciences, Inc. | Composition and method for delivery of biologically-active factors |
US5446090A (en) * | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
US20010055581A1 (en) * | 1994-03-18 | 2001-12-27 | Lawrence Tamarkin | Composition and method for delivery of biologically-active factors |
US5639725A (en) * | 1994-04-26 | 1997-06-17 | Children's Hospital Medical Center Corp. | Angiostatin protein |
US5521289A (en) * | 1994-07-29 | 1996-05-28 | Nanoprobes, Inc. | Small organometallic probes |
US5874226A (en) * | 1995-05-22 | 1999-02-23 | H. Lee Browne | In situ immunodetection of antigens |
US5685578A (en) * | 1995-09-25 | 1997-11-11 | Versa Technologies, Inc. | Locking mechanism for a trailer door |
DE19622628A1 (en) * | 1996-06-05 | 1997-12-11 | Boehringer Mannheim Gmbh | Stabilization of metal conjugates |
US6407218B1 (en) * | 1997-11-10 | 2002-06-18 | Cytimmune Sciences, Inc. | Method and compositions for enhancing immune response and for the production of in vitro mabs |
JP4588210B2 (en) * | 1997-11-10 | 2010-11-24 | サイティミューン サイエンシーズ, インコーポレイテッド | Methods and compositions for enhancing immune responses and for the production of monoclonal antibodies in vitro |
US7229841B2 (en) * | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
US5921927A (en) * | 1997-11-12 | 1999-07-13 | Axialtome Australia Pty. Ltd. | Positioning method and apparatus for X-ray tomography |
EP0922446A1 (en) * | 1997-12-03 | 1999-06-16 | Applied Research Systems Ars Holding N.V. | Solution-phase site-specific preparation of GRF-PEG conjugates |
JP3920462B2 (en) * | 1998-07-13 | 2007-05-30 | 株式会社大和化成研究所 | Aqueous solutions for obtaining noble metals by chemical reduction deposition |
JP2000160210A (en) * | 1998-11-25 | 2000-06-13 | Mitsuboshi Belting Ltd | Production of particulate |
MXPA02001857A (en) * | 1999-08-24 | 2003-07-14 | Cellgate Inc | Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties. |
AU1945901A (en) * | 1999-12-03 | 2001-06-12 | Surromed, Inc. | Hydroxylamine seeding of colloidal metal nanoparticles |
PT1280535E (en) * | 2000-01-11 | 2005-04-29 | Teva Pharma | PROCESSES FOR THE PREPARATION OF CLARITHROMYCINE POLYMORPHES |
US6530944B2 (en) * | 2000-02-08 | 2003-03-11 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
US6660058B1 (en) * | 2000-08-22 | 2003-12-09 | Nanopros, Inc. | Preparation of silver and silver alloyed nanoparticles in surfactant solutions |
JP2002080903A (en) | 2000-09-08 | 2002-03-22 | Japan Science & Technology Corp | Functional metallic fine particle with stabilized dispersion and semiconductor fine particle and method for producing the same |
JP5175020B2 (en) * | 2001-04-30 | 2013-04-03 | サイティミューン サイエンシーズ, インコーポレイテッド | Colloidal metal compositions and methods |
US20040018203A1 (en) * | 2001-06-08 | 2004-01-29 | Ira Pastan | Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates |
US6821529B2 (en) * | 2001-09-05 | 2004-11-23 | Deanna Jean Nelson | Oligo(ethylene glycoll)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers |
JP2003342742A (en) * | 2002-05-23 | 2003-12-03 | Risho Kogyo Co Ltd | Electroless gold plating liquid |
US20040204576A1 (en) * | 2002-07-02 | 2004-10-14 | Donald Jackson | Polynucleotides encoding a novel human phosphatase, BMY_HPP13 |
AU2003247587B2 (en) * | 2002-08-02 | 2009-07-09 | Immunogen, Inc. | Cytotoxic agents containing novel potent taxanes and their therapeutic use |
JP2008504216A (en) * | 2003-12-02 | 2008-02-14 | サイトイミューン サイエンシズ インコーポレイテッド | Methods and compositions for the production of monoclonal antibodies |
US20060222595A1 (en) * | 2005-03-31 | 2006-10-05 | Priyabrata Mukherjee | Nanoparticles for therapeutic and diagnostic applications |
-
2005
- 2005-01-28 US US11/046,204 patent/US20050175584A1/en not_active Abandoned
- 2005-01-28 CN CNA2005800097190A patent/CN1960825A/en active Pending
- 2005-01-28 CA CA002554755A patent/CA2554755A1/en not_active Abandoned
- 2005-01-28 AU AU2005209318A patent/AU2005209318B2/en not_active Ceased
- 2005-01-28 WO PCT/US2005/003454 patent/WO2005072893A1/en active Application Filing
- 2005-01-28 EP EP05722715A patent/EP1715971A4/en not_active Withdrawn
- 2005-01-28 JP JP2006551620A patent/JP4833862B2/en not_active Expired - Fee Related
-
2006
- 2006-07-25 IL IL177075A patent/IL177075A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2005209318B2 (en) | 2010-02-11 |
JP4833862B2 (en) | 2011-12-07 |
AU2005209318A1 (en) | 2005-08-11 |
IL177075A0 (en) | 2006-12-10 |
WO2005072893A1 (en) | 2005-08-11 |
IL177075A (en) | 2013-04-30 |
CN1960825A (en) | 2007-05-09 |
CA2554755A1 (en) | 2005-08-11 |
US20050175584A1 (en) | 2005-08-11 |
JP2007523067A (en) | 2007-08-16 |
EP1715971A4 (en) | 2010-10-13 |
EP1715971A1 (en) | 2006-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005072893A8 (en) | Functionalized colloidal metal compositions and methods | |
WO2005046572A3 (en) | Targeted delivery of controlled release polymer systems | |
WO2005110013A3 (en) | Methods, compositions, and preparations for delivery of immune response modifiers | |
WO2006064453A3 (en) | Targeting agents for molecular imaging | |
WO2005072061A3 (en) | Conjugates for cancer therapy and diagnosis | |
EP2985281A3 (en) | Isoindoline compounds for use in the treatment of cancer | |
WO2007113648A3 (en) | Ctla4 antibody combination therapy | |
WO2004111192A3 (en) | Targeted delivery to legumain-expressing cells | |
WO2004093795A3 (en) | Compositions for delivery of drug combinations | |
WO2008039218A3 (en) | Inhibitors of bruton's tyrosine kinase | |
WO2005112886A3 (en) | Methods and articles for the delivery of therapeutic agents | |
WO2005011734A3 (en) | Composition of a vegf antagonist and an anti-proliferative agent and its use for the treatment of cancer | |
WO2007064872A3 (en) | Urea compounds useful in the treatment of cancer | |
WO2006064451A3 (en) | Targeting contrast agents or targeting therapeutic agents for molecular imaging and therapy | |
WO2007047291A3 (en) | Anti-glypican-3 antibody | |
WO2007064945A3 (en) | Cancer therapies and pharmaceutical compositions used therein | |
WO2006041641A3 (en) | Therapeutic agents with decreased toxicity | |
WO2006108405A3 (en) | Nanoparticle/active ingredient conjugate | |
WO2004063342A3 (en) | Cellular delivery and activation polypeptide-nucleic acid complexes | |
WO2007077561A3 (en) | Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents | |
IL183274A0 (en) | Method for producing sterile suspensions or lyophilisates of poorly soluble basic peptide complexes, pharmaceutical formulations containing the same, and use thereof as medicaments | |
WO2006033006A3 (en) | Therapeutic combinations comprising poly(adp-ribose) polymerases inhibitor | |
WO2004074232A8 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
WO2008028965A3 (en) | Inhibitors of protein phosphatase 1, gadd34 and protein phosphatase 1/gadd34 complex, preparation and uses thereof | |
WO2008003943A3 (en) | Inhibition of alpha-synuclein aggregation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WR | Later publication of a revised version of an international search report | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005209318 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 177075 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2554755 Country of ref document: CA Ref document number: 2006551620 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2225/KOLNP/2006 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2005209318 Country of ref document: AU Date of ref document: 20050128 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005209318 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005722715 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580009719.0 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2005722715 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 204120 Country of ref document: IL |